With great power comes great responsibility: Promise and caution in the new psychedelic renaissance
Brain Disorders September 23, 2025 Matthew Halma, R. Levy, Joseph Varón 2 citations
Clinicians and researchers are showing increased interest in psychedelic-assisted therapy for patients who don't show improvement from using conventional antidepressants. This updated review integrates recent developments, including data on lesser-studied compounds like DMT and 5-MeO-DMT, findings from large clinical trials, and evolving regulatory landscapes. In treatment-resistant depression,...
DOI: 10.1016/j.dscb.2025.100286 (opens in new tab)
Psilocybin
MDMA
Ayahuasca
Hallucinogen
+8